Refine
Has Fulltext
- no (106)
Year of publication
Document Type
- Article (106) (remove)
Language
- English (106)
Is part of the Bibliography
- yes (106)
Keywords
- Conformational analysis (6)
- Cytotoxicity (5)
- Leguminosae (5)
- Antiplasmodial (4)
- DFT calculations (4)
- NMR (4)
- NMR spectroscopy (4)
- antiplasmodial (4)
- cytotoxicity (4)
- conformational analysis (3)
- Antiplasmodial activity (2)
- Asteraceae (2)
- Dynamic NMR (2)
- Flavone (2)
- Isoflavone (2)
- Mycobacterium tuberculosis (2)
- Plasmodium falciparum (2)
- Surface exudates (2)
- Tephrosia purpurea (2)
- Theoretical calculations (2)
- modified Mannich reaction (2)
- (+)-Tephrodin (1)
- 1-Methylthio-1-phenyl-1-silacyclohexane (1)
- 10-Methoxy-10,7 '-(chrysophanol anthrone)-chrysophanol (1)
- 3,4-Dihydroisoquinoline (1)
- 3-Hydroxyisoflavanone (1)
- 3-Oxo-14 alpha, 15 alpha-epoxyschizozygine (1)
- 4-Substituted cyclohexanones (1)
- 4-methylene-cyclohexyl pivalate (1)
- 6 alpha-Hydroxy-alpha-toxicarol (1)
- 8-oxohobartine (1)
- ALTONA equation (1)
- Alkenyl cyclohexanone (1)
- Alkenyl cyclohexenone (1)
- Aminonaphthol (1)
- Aminonaphthols (1)
- Anthraquinone (1)
- Anti-Plasmodial activity (1)
- Anti-inflammatory (1)
- Anticancer (1)
- Antileishmanial (1)
- Antimalarial plants (1)
- Antimicrobial (1)
- Antimicrobial activities (1)
- Apoptosis (1)
- Aristotelia chilensis (1)
- Asphodelaceae (1)
- Azadironolide (1)
- Benzazepine (1)
- Benzylbenzofuran (1)
- Biflavonoid (1)
- Block copolymer (1)
- Bulbine frutescens (1)
- C-13 (1)
- C. bonducella (1)
- Cancer (1)
- Carvotacetones (1)
- Cassiamin A (1)
- Cassiamin B (1)
- Celastraceae (1)
- Chalcone (1)
- Charge transfer (1)
- Chelates (1)
- Chemotaxonomy (1)
- Conformational equilibrium (1)
- Coumaronochromone (1)
- Coumestan (1)
- D. melleri (1)
- DFT and MP2 calculations (1)
- DFT structural study (1)
- DSC (1)
- Dalbergia melanoxylon (1)
- Dianellin (1)
- Dimeric anthraquinone (1)
- Diterpenoid (1)
- Docking (1)
- Dodonaea angustifolia (1)
- Dorstenia kameruniana (1)
- Dynamic NMR spectroscopy (1)
- E. schliebenii (1)
- Escherichia coli (1)
- F-19 (1)
- Flavanone (1)
- Furanocoumarin (1)
- Fusarium proliferatum (1)
- Fusicoccane diterpenes (1)
- GWD (1)
- Gas phase electron diffraction (1)
- H-1 (1)
- H. pubescens (1)
- Halogenation (1)
- Hammett-Brown plots (1)
- Hypoestes verticillaris (1)
- Isoflavanones (1)
- Isolations (1)
- Kenusanone F 7-methyl ether (1)
- Kniphofia foliosa (1)
- Knipholone cyclooxanthrone (1)
- LCST (1)
- Lannea rivae (1)
- Lannea schweinfurthii (1)
- Ligand design (1)
- Lignans (1)
- Limonoid (1)
- Lobelia tupa (1)
- Lonchocarpus bussei (1)
- Lonchocarpus eriocalyx (1)
- Low-temperature C-13 and Si-29 NMR (1)
- Malaria (1)
- Mammea usambarensis (1)
- Mammea-type coumarins (1)
- Maytenus boaria (1)
- Maytenus disticha (1)
- Maytenus spp. (1)
- Millettia dura (1)
- Millettia dura; (1)
- Millettia lasiantha (1)
- Millettia leucantha (1)
- Millettia micans (1)
- Millettia oblata ssp teitensis (1)
- Mitochondrial ROS (1)
- Modified Mannich reaction (1)
- Moraceae (1)
- Multi-drug resistance (1)
- Mundulea sericea (1)
- Naphthoxazines (1)
- Naphthoxazinoquinazolines (1)
- Naphthoxazinoquinazolinones (1)
- Ormocarpum kirkii (1)
- Oxidation (1)
- P-31 NMR (1)
- PWD (1)
- Palladium (1)
- Penicillium digitatum (1)
- Pentylsedinine (1)
- Phenylanthraquinone (1)
- Piperidine alkaloid (1)
- Platycelphium voense (1)
- Platyisoflavanone (1)
- Pleurotus ostreatus (1)
- Pterocarpan (1)
- Quantum chemical calculations (1)
- Quinazolines (1)
- RAFT polymerization (1)
- Reaction products (1)
- Reagents (1)
- Renewable resources (1)
- Responsive polymer (1)
- Ring current effect (1)
- Roots (1)
- S li-gands (1)
- Schizophrenic self-assembly (1)
- Schizozygane indoline alkaloid (1)
- Schizozygia coffaeoides (1)
- Senecio roseiflorus (1)
- Simulation of H-1 NMR spectra (1)
- Sophoronol-7-methyl ether (1)
- Sphaeranthus bullatus (1)
- Staphylococcus aureus (1)
- Stem (1)
- Stem bark (1)
- Stereochemistry (1)
- Structure revision (1)
- Sulfobetaine methacrylate (1)
- Tephrosia aequilata (1)
- Tephrosia subtriflora (1)
- Tephrosia villosa (1)
- Terpurinflavone (1)
- Thienopyridine (1)
- Toonacilin (1)
- Toonapubesins F (1)
- Turraea nilotica (1)
- Turraea robusta (1)
- UCST (1)
- Xanthone (1)
- Zanthoxylum holstzianum (1)
- Zanthoxylum leprieurii (1)
- [4+2] cycloaddition (1)
- activity (1)
- aequichalcone A (1)
- aequichalcone B (1)
- aequichalcone C (1)
- alkaloid (1)
- antileishmanial (1)
- antimycobacterial activity (1)
- benzophenanthridine alkaloid (1)
- beta-dihydroagarofuran-type sesquiterpene (1)
- chalcone (1)
- crystal structure (1)
- cyclic imines (1)
- cycloaddition (1)
- cytotoxic (1)
- dihydro-beta-agarofuran (1)
- dihydromyricetin (1)
- dihydromyricetin-3-O-beta-glucoside (1)
- dynamic NMR spectroscopy (1)
- exo-methylene conformational effect at cyclohexane (1)
- flavanonol (1)
- flavonol (1)
- holstzianoquinoline; (1)
- indole alkaloids (1)
- isoflavone (1)
- leguminosae (1)
- marker compound (1)
- medicinal mushrooms (1)
- nAChR (1)
- norcaesalpin D (1)
- ortho-quinone methide (o-QMs) (1)
- phytomedicine (1)
- prenylated flavanonol (1)
- pristimerin (1)
- pterocarpan (1)
- pterocarpene (1)
- quantum chemical calculations (1)
- restricted N-S rotation (1)
- retrochalcone (1)
- rutaceae (1)
- seco-Anthraquinone (1)
- sesquiterpene (1)
- spectroscopy (1)
- starch phosphorylation (1)
- subtriflavanonol (1)
- trans-fagaramide (1)
- tuberculosis (1)
Institute
Background: In Kenya, several species of the genus Maytenus are used in traditional medicine to treat many diseases including malaria. In this study, phytochemical constituents and extracts of Maytenus undata, M. putterlickioides, M. senegalensis and M. heterophylla were evaluated to determine compound/s responsible for antimalarial activity.
Objective: To isolate antiplasmodial compounds from these plant species which could be used as marker compounds in the standardization of their extracts as a phytomedicine for malaria.
Methods: Constituents were isolated through activity-guided fractionation of the MeOH/CHCl3 (1:1) extracts and in vitro inhibition of Plasmodium falciparum. Cytotoxicity was evaluated using Vero cells and the compounds were elucidated on the basis of NMR spectroscopy.
Results: Fractionation of the extracts resulted in the isolation of ten known compounds. Compound 1 showed promising antiplasmodial activity with IC50, 3.63 and 3.95 ng/ml against chloroquine sensitive (D6) and resistant (W2) P. falciparum, respectively and moderate cytotoxicity (CC50, 37.5 ng/ml) against Vero E6 cells. The other compounds showed weak antiplasmodial (IC50 > 1.93 mu g/ml) and cytotoxic (CC50 > 39.52 mu g/ml) activities against P. falciparum and Vero E6 cells, respectively.
Conclusion: (20 alpha)-3-hydroxy-2-oxo-24-nor-friedela-1(10),3,5,7-tetraen-carboxylic acid-(29)-methyl-ester (pristimerin) (1) was the most active marker and lead compound that warrants further investigation as a template for the development of new antimalarial drugs. Pristimerin is reported for the first time in M. putterlickioides. 3-Hydroxyolean-12-en-28-oic acid (oleanolic acid) (5), stigmast-5-en-3-ol (beta-sitosterol) (6), 3-oxo-28-friedelanoic acid (7), olean-12-en-3-ol (beta-amyrin) (8), lup-20(29)-en-3-ol (lupeol) (9) and lup-20(29)-en-3-one (lupenone) (10) are reported for the first time in M. undata.
Background: Malaria is an old life-threatening parasitic disease that is still affecting many people, mainly children living in sub-Saharan Africa. Availability of effective antimalarial drugs played a significant role in the treatment and control of malaria. However, recent information on the emergence of P. falciparum parasites resistant to one of the artemisinin-based combination therapies suggests the need for discovery of new drug molecules. Therefore, this study aimed to evaluate the antiplasmodial activity of extracts, fractions and isolated compound from medicinal plants traditionally used in the treatment of malaria in Tanzania. Methods: Dry powdered plant materials were extracted by cold macerations using different solvents. Norcaesalpin D was isolated by column chromatography from dichloromethane root extract of Caesalpinia bonducella and its structure was assigned based on the spectral data. Crude extracts, fractions and isolated compound were evaluated for antiplasmodial activity against chloroquine-sensitive P. falciparum (3D7), chloroquine-resistant P. falciparum (Dd2, K1) and artemisinin-resistant P. falciparum (IPC 5202 Battambang, IPC 4912 Mondolkiri) strains using the parasite lactate dehydrogenase assay. Results: The results indicated that extracts of Erythrina schliebenii, Holarrhena pubescens, Dissotis melleri and C. bonducella exhibited antiplasmodial activity against Dd2 parasites. Ethanolic root extract of E. schliebenii had an IC50 of 1.87 mu g/mL while methanolic and ethanolic root extracts of H. pubescens exhibited an IC50 = 2.05 mu g/mL and IC50 = 2.43 mu g/mL, respectively. Fractions from H. pubescens and C. bonducella roots were found to be highly active against K1, Dd2 and artemisinin-resistant parasites. Norcaesalpin D from C. bonducella root extract was active with IC50 of 0.98, 1.85 and 2.13 mu g/mL against 3D7, Dd2 and IPC 4912-Mondolkiri parasites, respectively. Conclusions: Antiplasmodial activity of norcaesalpin D and extracts of E. schliebenii, H. pubescens, D. melleri and C. bonducella reported in this study requires further attention for the discovery of antimalarial lead compounds for future drug development.
A new isoflavone, 8-prenylmilldrone (1), and four new rotenoids, oblarotenoids A-D (2-5), along with nine known compounds (6-14), were isolated from the CH2Cl2/CH3OH (1:1) extract of the leaves of Millettia oblata ssp. teitensis by chromatographic separation. The purified compounds were identified by NMR spectroscopic and mass spectrometric analyses, whereas the absolute configurations of the rotenoids were established on the basis of chiroptical data and in some cases by single-crystal X-ray crystallography. Maximaisoflavone J (11) and oblarotenoid C (4) showed weak activity against the human breast cancer cell line MDA-MB-231 with IC50 values of 33.3 and 93.8 mu M, respectively.
The CH2Cl2/MeOH (1:1) extract of the aerial parts of Tephrosia subtriflora afforded a new flavanonol, named subtriflavanonol (1), along with the known flavanone spinoflavanone B, and the known flavanonols MS-II (2) and mundulinol. The structures were elucidated by the use of NMR spectroscopy and mass spectrometry. The absolute configuration of the flavanonols was determined based on quantum chemical ECD calculations. In the antiplasmodial assay, compound 2 showed the highest activity against chloroquine-sensitive Plasmodiumfalciparum reference clones (D6 and 3D7), artemisinin-sensitive isolate (F32-TEM) as well as field isolate (KSM 009) with IC50 values 1.4-4.6M without significant cytotoxicity against Vero and HEp2 cell lines (IC50>100M). The new compound (1) showed weak antiplasmodial activity, IC50 12.5-24.2M, but also showed selective anticancer activity against HEp2 cell line (CC50 16.9M). [GRAPHICS] .
Phytochemical investigation of the CH2Cl2/MeOH (1:1) extract of the roots of Lannea rivae (Chiov) Sacleux (Anacardiaceae) led to the isolation of a new alkenyl cyclohexenone derivative: (4R,6S)-4,6-dihydroxy-6-((Z)-nonadec-14′-en-1-yl)cyclohex-2-en-1-one (1), and a new alkenyl cyclohexanol derivative: (2S*,4R*,5S*)-2,4,5-trihydroxy-2-((Z)-nonadec-14′-en-1-yl)cyclohexanone (2) along with four known compounds, namely epicatechin gallate, taraxerol, taraxerone and β-sitosterol; while the stem bark afforded two known compounds, daucosterol and lupeol. Similar investigation of the roots of Lannea schweinfurthii (Engl.) Engl. led to the isolation of four known compounds: 3-((E)-nonadec-16′-enyl)phenol, 1-((E)-heptadec-14′-enyl)cyclohex-4-ene-1,3-diol, catechin, and 1-((E)-pentadec-12′-enyl)cyclohex-4-ene-1,3-diol. The structures of the isolated compounds were determined by NMR spectroscopy and mass spectrometry. The absolute configuration of compound 1 was established by quantum chemical ECD calculations. In an antibacterial activity assay using the microbroth kinetic method, compound 1 showed moderate activity against Escherichia coli while compound 2 exhibited moderate activity against Staphylococcus aureus. Compound 1 also showed moderate activity against E. coli using the disc diffusion method. The roots extract of L. rivae was notably cytotoxic against both the DU-145 prostate cancer cell line and the Vero mammalian cell line (CC50 = 5.24 and 5.20 μg/mL, respectively). Compound 1 was also strongly cytotoxic against the DU-145 cell line (CC50 = 0.55 μg/mL) but showed no observable cytotoxicity (CC50 > 100 μg/mL) against the Vero cell line. The roots extract of L. rivae and L. schweinfurthii, epicatechin gallate as well as compound 1 exhibited inhibition of carageenan-induced inflammation.
The drimane sesquiterpenoids drimenin, cinnamolide, dendocarbin A, and polygodial were purified from the Canelo tree (Drimys winteri) and chemically characterized by spectroscopic methods. The pharmacological activity of these natural compounds were determined on hα4β2, hα3β4, and hα7 nicotinic acetylcholine receptors (AChRs) by Ca2+ influx measurements. The results established that drimane sesquiterpenoids inhibit AChRs with the following selectivity: hα4β2 > hα3β4 > hα7. In the case of hα4β2 AChRs, the following potency rank order was determined (IC50’s in μM): drimenin (0.97 ± 0.35) > cinnamolide (1.57 ± 0.36) > polygodial (62.5 ± 19.9) ≫ dendocarbin A (no activity). To determine putative structural features underlying the differences in inhibitory potency at hα4β2 AChRs, additional structure–activity relationship and molecular docking experiments were performed. The Ca2+ influx and structural results supported a noncompetitive mechanism of inhibition, where drimenin interacted with luminal and nonluminal (TMD-β2 intrasubunit) sites. The structure–activity relationship results, i.e., the lower the ligand polarity, the higher the inhibitory potency, supported the nonluminal interaction. Ligand binding to both sites might inhibit the hα4β2 AChR by a cooperative mechanism, as shown experimentally (nH > 1). Drimenin could be used as a molecular scaffold for the development of more potent inhibitors with higher selectivity for the hα4β2 AChR.
As part of a project studying the secondary metabolites extracted from the Chilean flora, we report herein three new beta-agarofuran sesquiterpenes, namely (1S,4S,5S,6R,7R,8R,9R,10S)-6-acetoxy-4,9-dihydroxy-2,2,5a,9-tetramethyloctahydro-2H-3,9a-methanobenzo[b] oxepine-5,10-diylbis(furan-3-carboxylate), C27H32O11, (II), (1S,4S,5S,6R,7R,9S,10S)-6-acetoxy-9-hydroxy-2,2,5a, 9-tetramethyloctahydro-2H-3,9a-methanobenzo[ b] oxepine-5,10-diyl bis(furan-3-carboxylate), C27H32O10, (III), and (1S,4S,5S,6R,7R,9S,10S)-6-acetoxy-10-(benzoyloxy)-9-hydroxy-2,2,5a,9-tetramethyloctahydro-2H-3,9a-methanobenzo[b]oxepin-5-yl furan-3-carboxylate, C29H34O9, (IV), obtained from the seeds of Maytenus boaria and closely associated with a recently published relative [Paz et al. (2017). Acta Cryst. C73, 451-457]. In the (isomorphic) structures of (II) and (III), the central decalin system is esterified with an acetate group at site 1 and furoate groups at sites 6 and 9, and differ at site 8, with an OH group in (II) and no substituent in (III). This position is also unsubstituted in (IV), with site 6 being occupied by a benzoate group. The chirality of the skeletons is described as 1S, 4S, 5S, 6R, 7R, 8R, 9R, 10S in (II) and 1S, 4S, 5S, 6R, 7R, 9S, 10S in (III) and (IV), matching the chirality suggested by NMR studies. This difference in the chirality sequence among the title structures (in spite of the fact that the three skeletons are absolutely isostructural) is due to the differences in the environment of site 8, i.e. OH in (II) and H in (III) and (IV). This diversity in substitution, in turn, is responsible for the differences in the hydrogen-bonding schemes, which is discussed.
Chromatographic separation of the extract of the roots of Dorstenia kameruniana (family Moraceae) led to the isolation of three new benzylbenzofuran derivatives, 2-(p-hydroxybenzyl)benzofuran-6-ol (1), 2-(p-hydroxybenzyl)-7-methoxybenzofuran-6-ol (2) and 2-(p-hydroxy)-3-(3-methylbut-2-en-1-yl)benzyl)benzofuran-6-ol (3) (named dorsmerunin A, B and C, respectively), along with the known furanocoumarin, bergapten (4). The twigs of Dorstenia kameruniana also produced compounds 1-4 as well as the known chalcone licoagrochalcone A (5). The structures were elucidated by NMR spectroscopy and mass spectrometry. The isolated compounds displayed cytotoxicity against the sensitive CCRF-CEM and multidrug-resistant CEM/ADR5000 leukemia cells, where compounds 4 and 5 had the highest activities (IC50 values of 7.17 mu M and 5.16 mu M, respectively) against CCRF-CEM leukemia cells. Compound 5 also showed cytotoxicity against 7 sensitive or drug-resistant solid tumor cell lines (breast carcinoma, colon carcinoma, glioblastoma), with IC50 below 50 mu M, whilst 4 showed selective activity.
Bioassay-guided screening of Hypoestes verticillaris whole plant CH2Cl2: MeOH (1:1) extract for anti-plasmodial activity yielded four new compounds: two lignans 2, 6-dimethoxysavinin (1), 2,6-dimethoxy-(7E)-7,8-dehydroheliobuphthalmin (2); and two fusicoccane diterpenoids: 11(12)-epoxyhypoestenone (3) and 3(11)-epoxyhypoestenone (4). The chemical structures were determined using various spectroscopic techniques: UV-vis, IR, CD, 1D, 2D and MS. Two fractions (RAO-43B and RAO-43D) and the isolated compounds were tested for activity against CQ susceptible (D6) and resistant (W2) Plasmodium falciparum parasite strains, in vitro and the IC50 values determined. While the whole extract and some resultant fractions displayed moderate activity, the isolated compounds exhibited mild anti-plasmodial activity against the both strains ranging from IC50 value of 328 mu M in 1 to 93 mu M in 3 against W2 strain.
Background: While incidences of cancer are continuously increasing, drug resistance of malignant cells is observed towards almost all pharmaceuticals. Several isoflavonoids and flavonoids are known for their cytotoxicity towards various cancer cells. Methods: The cytotoxicity of compounds was determined based on the resazurin reduction assay. Caspases activation was evaluated using the caspase-Glo assay. Flow cytometry was used to analyze the cell cycle (propodium iodide (PI) staining), apoptosis (annexin V/PI staining), mitochondrial membrane potential (MMP) (JC-1) and reactive oxygen species (ROS) (H2DCFH-DA). CCRF-CEM leukemia cells were used as model cells for mechanistic studies. Results: Compounds 1, 2 and 4 displayed IC50 values below 20 mu M towards CCRF-CEM and CEM/ADR5000 leukemia cells, and were further tested towards a panel of 7 carcinoma cells. The IC50 values of the compounds against carcinoma cells varied from 16.90 mu M (in resistant U87MG.Delta EGFR glioblastoma cells) to 48.67 mu M (against HepG2 hepatocarcinoma cells) for 1, from 7.85 mu M (in U87MG.Delta EGFR cells) to 14.44 mu M (in resistant MDA-MB231/BCRP breast adenocarcinoma cells) for 2, from 4.96 mu M (towards U87MG.Delta EGFRcells) to 7.76 mu M (against MDA-MB231/BCRP cells) for 4, and from 0.07 mu M (against MDA-MB231 cells) to 2.15 mu M (against HepG2 cells) for doxorubicin. Compounds 2 and 4 induced apoptosis in CCRF-CEM cells mediated by MMP alteration and increased ROS production. Conclusion: The present report indicates that isoflavones and biflavonoids from Ormocarpum kirkii are cytotoxic compounds with the potential of being exploited in cancer chemotherapy. Compounds 2 and 4 deserve further studies to develop new anticancer drugs to fight sensitive and resistant cancer cell lines.